Financial Architects Inc cut its position in UnitedHealth Group Incorporated (NYSE:UNH) by 2.5% during the second quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 1,986 shares of the healthcare conglomerate’s stock after selling 51 shares during the period. Financial Architects Inc’s holdings in UnitedHealth Group were worth $368,000 as of its most recent SEC filing.

Several other institutional investors also recently bought and sold shares of UNH. Patriot Financial Group Insurance Agency LLC raised its position in UnitedHealth Group by 1,722.9% in the first quarter. Patriot Financial Group Insurance Agency LLC now owns 638 shares of the healthcare conglomerate’s stock worth $106,000 after buying an additional 603 shares in the last quarter. Cribstone Capital Management LLC raised its position in UnitedHealth Group by 22.6% in the first quarter. Cribstone Capital Management LLC now owns 678 shares of the healthcare conglomerate’s stock worth $113,000 after buying an additional 125 shares in the last quarter. Kings Point Capital Management raised its position in UnitedHealth Group by 27.9% in the first quarter. Kings Point Capital Management now owns 687 shares of the healthcare conglomerate’s stock worth $113,000 after buying an additional 150 shares in the last quarter. Founders Capital Management bought a new position in UnitedHealth Group during the first quarter worth approximately $135,000. Finally, Parkside Financial Bank & Trust raised its position in UnitedHealth Group by 1.4% in the first quarter. Parkside Financial Bank & Trust now owns 854 shares of the healthcare conglomerate’s stock worth $140,000 after buying an additional 12 shares in the last quarter. 86.21% of the stock is currently owned by institutional investors.

Shares of UnitedHealth Group Incorporated (NYSE UNH) traded down 0.72% on Wednesday, hitting $193.09. The company had a trading volume of 816,038 shares. The stock has a market capitalization of $186.69 billion, a PE ratio of 23.20 and a beta of 0.64. The firm’s 50 day moving average price is $189.87 and its 200-day moving average price is $175.41. UnitedHealth Group Incorporated has a 52 week low of $132.39 and a 52 week high of $196.04.

UnitedHealth Group (NYSE:UNH) last posted its quarterly earnings data on Tuesday, July 18th. The healthcare conglomerate reported $2.46 earnings per share for the quarter, beating the Zacks’ consensus estimate of $2.38 by $0.08. UnitedHealth Group had a return on equity of 21.52% and a net margin of 4.32%. The company had revenue of $50.05 billion during the quarter, compared to analyst estimates of $49.97 billion. During the same quarter last year, the company earned $1.96 EPS. The firm’s revenue for the quarter was up 7.7% on a year-over-year basis. Analysts forecast that UnitedHealth Group Incorporated will post $9.87 earnings per share for the current fiscal year.

The business also recently disclosed a quarterly dividend, which will be paid on Tuesday, September 19th. Investors of record on Friday, September 8th will be given a dividend of $0.75 per share. This represents a $3.00 dividend on an annualized basis and a yield of 1.54%. UnitedHealth Group’s dividend payout ratio (DPR) is presently 35.13%.

COPYRIGHT VIOLATION NOTICE: “UnitedHealth Group Incorporated (UNH) Stake Lowered by Financial Architects Inc” was reported by Daily Political and is owned by of Daily Political. If you are reading this piece on another publication, it was illegally copied and republished in violation of US & international trademark and copyright laws. The original version of this piece can be read at https://www.dailypolitical.com/2017/08/16/unitedhealth-group-incorporated-unh-stake-lowered-by-financial-architects-inc.html.

A number of equities analysts recently commented on the company. Jefferies Group LLC reaffirmed a “buy” rating and issued a $192.00 price objective on shares of UnitedHealth Group in a research note on Friday, May 19th. Vetr lowered UnitedHealth Group from a “buy” rating to a “hold” rating and set a $179.00 price objective on the stock. in a research note on Monday, April 24th. Cantor Fitzgerald reaffirmed an “overweight” rating and issued a $205.00 price objective (up from $200.00) on shares of UnitedHealth Group in a research note on Saturday, April 22nd. Zacks Investment Research raised UnitedHealth Group from a “hold” rating to a “buy” rating and set a $201.00 price objective on the stock in a research note on Wednesday, June 7th. Finally, Barclays PLC lifted their price objective on UnitedHealth Group from $200.00 to $217.00 and gave the stock an “overweight” rating in a research note on Wednesday, July 19th. One investment analyst has rated the stock with a hold rating and twenty-four have issued a buy rating to the stock. The stock currently has an average rating of “Buy” and a consensus price target of $202.20.

In other UnitedHealth Group news, Director Gail R. Wilensky sold 5,540 shares of UnitedHealth Group stock in a transaction on Friday, June 2nd. The stock was sold at an average price of $178.74, for a total value of $990,219.60. Following the completion of the sale, the director now owns 60,516 shares of the company’s stock, valued at approximately $10,816,629.84. The transaction was disclosed in a filing with the SEC, which can be accessed through the SEC website. Also, Director William C. Ballard, Jr. sold 5,000 shares of UnitedHealth Group stock in a transaction on Wednesday, June 7th. The stock was sold at an average price of $182.64, for a total value of $913,200.00. Following the completion of the sale, the director now directly owns 75,735 shares of the company’s stock, valued at approximately $13,832,240.40. The disclosure for this sale can be found here. In the last ninety days, insiders have sold 15,540 shares of company stock valued at $2,873,320. 0.89% of the stock is owned by corporate insiders.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated is a health and well-being company. The Company operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight and OptumRx. It conducts its operations through two business platforms: health benefits operating under UnitedHealthcare and health services operating under Optum.

Want to see what other hedge funds are holding UNH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for UnitedHealth Group Incorporated (NYSE:UNH).

Institutional Ownership by Quarter for UnitedHealth Group (NYSE:UNH)

Receive News & Ratings for UnitedHealth Group Incorporated Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group Incorporated and related companies with MarketBeat.com's FREE daily email newsletter.